brain cancer Archives - Double Bond Pharmaceutical

Double Bond Pharma signs agreement for distribution of Helixor products

By admin|2018-11-20T23:28:02+01:00November 19th, 2018|

Double Bond Pharma signs agreement for distribution of Helixor products TUE, MAY 29, 2018 08:00 CET Double Bond Pharmaceutical (DBP) and Helixor Heilmittel GmbH have today signed an agreement for distribution of Helixor products in Sweden. The distribution will be held through Drugsson AB. Helixor [...]

Double Bond aims at adaptive design for SI-053 Phase I

By admin|2018-11-20T23:39:15+01:00November 19th, 2018|

Double Bond aims at adaptive design for SI-053 Phase I FRI, MAY 04, 2018 10:19 CET Double Bond Pharmaceutical (DBP) has signed a service contract with Cytel Inc, a leading provider of clinical research services and software, to develop an adaptive model-based study design for [...]